New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration-- and researchers now think they ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

Practice-changing studies in dry age-related macular degeneration (AMD) and promising new directions in wet AMD, presented at ...

Dr. Ali points out that historically, there haven’t been any advanced dry macular degeneration treatment options approved by the FDA. However, that changed in 2023. “The two FDA approved ...

TUESDAY, Nov. 5, 2024 (HealthDay News) -- Current treatments sometimes fail to help people with "wet" age-related macular ...

A study from researchers at Wilmer Eye Institute, Johns Hopkins Medicine explains not only why some patients with wet ...

A new study explains not only why some patients with wet age-related macular degeneration (or 'wet' AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

The Healthcare Private Equity team has advised Retina Consultants of America (RCA) and Webster Equity Partners in the sale of ...